NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020

  • Written by ACN Newswire

image

HONG KONG, Feb 10, 2020 - (ACN Newswire) - Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in relation to its repurposed drug candidate, SACT-1, for the treatment of neuroblastoma, a...

Read more: Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for...